March 14, 2018 / 8:21 PM / 3 months ago

BRIEF-Catalyst Pharmaceuticals Announces Q4 Gaap Loss Per Share $0.06

* CATALYST PHARMACEUTICALS ANNOUNCES FOURTH QUARTER AND YEAR-END 2017 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

* Q4 GAAP LOSS PER SHARE $0.06

* Q4 EARNINGS PER SHARE VIEW $-0.06 — THOMSON REUTERS I/B/E/S

* ‍CATALYST HAD NO REVENUES IN YEAR 2017 OR 2016​

* CATALYST PHARMACEUTICALS - ‍BASED ON CURRENT FINANCIAL POSITION, CASH FORECAST CO BELIEVES IT HAS SUFFICIENT FUNDS TO SUPPORT OPERATIONS THROUGH 2019​ Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below